The Delphi logo

Statement regarding costs of buprenorphine

Around the beginning of May 2018 Delphi Medical were made aware of the potential risk of cost increases in buprenorphine secondary to the implementation of a central pricing control mechanism. The most important issue from a Delphi Medical point of view is to ensure that our patients receiving buprenorphine have continuity of care as part … Continued

A group of people stand together in an office

Delphi Medical joins The Calico Group

Leading independent provider of drug and alcohol treatment services, Delphi Medical, has officially become part of The Calico Group.